To identify protein regulators that interacted with NCOA3 in CRC cells, we performed immunoprecipitation combined with mass spectrometry (IP‐MS) in SW620, HCT116, and HT29 CRC cells with IgG control or NCOA3 antibodies. This evidence concerns the gene NCOA3 and colorectal carcinoma.